Yet another MOU with a company few investors know. Also a privately held company, so no insight into their market value.
AMY's process has now been around for years and these guys want to test some material to see if it works? What about all the other Tier One testing that happened years ago. Nothing happened. The signs are telling that AMY may have a novel process but something is amiss. Likely to costly or the CEO is to stubborn to understand any potential deals.
Larry, no one cares about more patents or MOUs. Investors want iron clad deals with dollar value. This is the same old false hope that Larry brings to the table.
Hundreds of millions of dollars are getting poured into this space and so far AMY is unable to get a dime.
If there is nothing wrong with AMY's process/product, then something else has to be the problem.... I wonder what that is???